Triple

T5689042
Position Surface form Disambiguated ID Type / Status
Subject FDA traditional approval E125382 entity
Predicate reviewedBy P1394 FINISHED
Object FDA Center for Biologics Evaluation and Research E86214 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: FDA Center for Biologics Evaluation and Research | Statement: [FDA traditional approval, reviewedBy, FDA Center for Biologics Evaluation and Research]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: FDA Center for Biologics Evaluation and Research
Context triple: [FDA traditional approval, reviewedBy, FDA Center for Biologics Evaluation and Research]
  • A. Center for Biologics Evaluation and Research chosen
    The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
  • B. Center for Drug Evaluation and Research
    The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
  • C. Office of Compliance and Biologics Quality
    The Office of Compliance and Biologics Quality is a division within the FDA’s biologics center responsible for ensuring the safety, quality, and regulatory compliance of biological products such as vaccines, blood, and cellular therapies.
  • D. Center for Devices and Radiological Health
    The Center for Devices and Radiological Health is the U.S. FDA division responsible for regulating medical devices and radiation-emitting products to ensure their safety and effectiveness.
  • E. National Center for Toxicological Research
    The National Center for Toxicological Research is a U.S. federal research facility that conducts scientific studies to support the safety evaluation and regulatory decisions of the Food and Drug Administration.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c0082bb19c8190823a4facd3cba79b completed March 22, 2026, 3:18 p.m.
NER Named-entity recognition batch_69c023e1c6148190aeae7620bd9ee9d4 completed March 22, 2026, 5:16 p.m.
NED1 Entity disambiguation (via context triple) batch_69c07dd1758c8190ad92f250e5927c0b completed March 22, 2026, 11:40 p.m.
Created at: March 22, 2026, 3:44 p.m.